NASDAQ$ULBI

Ultralife Corporation · Q3 2022 earnings

Q3 2022 earnings · · Investor relations

Briefing

Reported an operating loss of $0.6 million and adjusted EBITDA of $1.3 million on revenue of $33.2 million.

Ultralife Corporation reported a revenue of $33.2 million for the third quarter ended September 30, 2022, representing a 52.7% increase compared to the same period last year. The company experienced an operating loss of $0.6 million and an adjusted EBITDA of $1.3 million.

  • Government/defense revenue doubled year-over-year.
  • Total company revenue increased by 53% due to government/defense revenue and the addition of Excell.
  • Backlog now exceeds $100 million, positioning the company well for near-term revenue increases.
  • Gross margins and profitability were pressured by production inefficiencies associated with supply chain disruptions and input cost inflation.

Headline financials

Total Revenue

$33.2M

Previous: $21.8M+52.7%
EPS (adj)

-$0.01

Previous: -$0.05+80.0%
Adjusted EBITDA

$1.3M

No prior period
Capital Expenditures

-$1.4M

Previous: -$2.32M+39.9%
Free Cash Flow

-$1.64M

Previous: -$2.91M+43.8%
Net Income

-$239K

Previous: -$585K+59.1%
Operating Income

-$586K

Previous: -$779K+24.8%
Gross Profit

$6.72M

Previous: $5.11M+31.5%
Cash & Equivalents

$4.98M

Previous: $15.8M-68.4%
Total Assets

$168M

Previous: $137M+22.8%

Revenue & EPS history

Ultralife · Revenue · Quarterly

$33.2M

Q3 2022+52.7%vs Q3 2021
Beat estimate in 7 of 14 quarters(50%)
ActualEstimate

Revenue by segment

Ultralife · $4.7M total across 1 segment · Q3 2022

  • Communications Systems
    $4.7M+161.1%

Forward guidance

Ultralife is positioned well for near-term revenue increases and remains committed to advancing several transformational projects and new product opportunities to drive long-term revenue growth.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2022

Historical avgQ3 2022

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+5.4%

Avg return

30 days after

46%

30 / 65 earnings

Positive

+56.6%

Q2 2023

Best reaction

-26.7%

Q2 2012

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-14.3%-16.4%-4.6%
Q4 2025+8.3%+22.9%+28.5%
Q3 2025-9.0%-5.4%+4.7%
Q1 2025+2.9%+13.1%+57.8%
Q4 2024-6.1%-16.0%-18.2%
Q3 2024-14.3%-16.5%-18.3%
Q2 2024-3.1%-4.1%-1.8%
Q1 2024+30.5%+34.0%+29.4%
Q4 2023+16.5%+11.6%+6.6%
Q3 2023-22.3%-19.3%-18.2%
Q2 2023+56.6%+70.8%+87.4%
Q1 2023+3.6%-1.2%+4.9%
Q4 2022+0.5%-3.2%-0.2%
Q3 2022-4.6%-7.1%-15.4%
Q2 2022-4.1%-1.9%+8.8%
Q1 2022+6.4%+3.9%+7.1%
Q4 2021-7.4%-9.1%+0.9%
Q3 2021-9.3%-7.4%-19.9%
Q2 2021-6.3%-4.8%-5.3%
Q1 2021-1.4%-3.5%+14.0%
Q4 2020+8.2%+24.6%+11.9%
Q3 2020-9.8%-6.5%+20.1%
Q2 2020+1.7%+1.0%-9.7%
Q1 2020+7.6%+19.7%+19.3%
Q4 2019+11.4%+12.7%+0.0%
Q3 2019-7.1%-5.5%-6.4%
Q2 2019+6.0%-1.8%-1.8%
Q1 2019-18.1%-23.2%-30.0%
Q4 2018+4.1%+12.9%+26.1%
Q3 2018+10.9%+9.7%+8.4%
Q2 2018-3.5%-1.0%-13.5%
Q1 2018+3.3%+0.0%+12.1%
Q4 2017+7.6%+8.3%+19.7%
Q3 2017-14.3%-12.2%-12.9%
Q2 2017-2.2%-4.3%-6.5%
Q1 2017+7.2%+6.3%+20.7%
Q4 2016-1.0%+6.9%+8.8%
Q3 2016-7.8%-8.9%+6.7%
Q2 2016-7.6%-13.8%-11.0%
Q1 2016-11.0%
Q4 2015-4.5%
Q3 2015+5.3%
Q2 2015+0.0%
Q1 2015+1.5%
Q4 2014+9.7%
Q3 2014+5.7%
Q2 2014-8.3%
Q1 2014+7.2%
Q4 2013-5.2%
Q3 2013-4.5%
Q2 2013-0.3%
Q1 2013+1.8%
Q4 2012+11.2%
Q3 2012+5.9%
Q2 2012-26.7%
Q1 2011+0.5%
Q1 2012-1.0%
Q4 2011+0.6%
Q4 2009+0.6%
Q3 2011-3.0%
Q3 2010-3.0%
Q4 2010-0.2%
Q2 2010-0.2%
Q2 2011-0.2%
Q1 2010+4.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro